Revolutionizing Drug Delivery with Gelteq's Innovative Platform
Gelteq Limited, a pioneering company in clinical and scientific advancements, has unveiled impressive preclinical findings that emphasize the effectiveness, flexibility, and safety of its novel gel-based oral delivery system. This groundbreaking research addresses one of the most significant challenges in pharmaceutical development, particularly the oral delivery of oil-soluble and poorly soluble drugs.
Key Findings from Preclinical Studies
Through two meticulously designed preclinical studies, Gelteq demonstrated that its gel platform significantly enhances the absorption of certain compounds. Notably, an oil-soluble compound showcased a staggering 300 percent increase in bioavailability during the first hour when incorporated into Gelteq’s gel base, setting a new benchmark for rapid onset of action in drug formulations.
The improvements did not halt there. In a 24-hour observation, overall absorption of the same compound was elevated by over 20 percent compared to an existing FDA-approved product. This vital data illustrates how Gelteq’s gel matrix effectively supports the delivery of lipophilic compounds, reducing the reliance on high levels of emulsifiers.
Mechanism of Action in the Digestive System
A crucial aspect of Gelteq’s platform lies in its ability to control the movement of drugs through the digestive system, facilitating targeted release and optimal absorption. The data indicates that the active ingredients are disseminated uniformly along the small intestine. This extended dispersal behavior not only bolsters absorption but also maximizes the exposure of the drug across a larger intestinal surface area.
A Safer Alternative for Drug Formulation
The studies further revealed that Gelteq’s gel can be formulated for efficient transit, allowing for rapid early absorption of active pharmaceutical ingredients (APIs). Its structural matrix was found to disperse effectively toward the large intestine, underscoring its safety and compatibility for oral use.
These significant advancements highlight Gelteq’s capability to present a versatile alternative to traditional oral delivery mechanisms for challenging drug formulations. In a landscape where over 40 percent of approved drugs grapple with solubility and bioavailability issues, Gelteq's innovative platform may serve as a streamlined solution that mitigates developmental complexities and enhances bioavailability, potentially rejuvenating previously shelved or difficult molecules.
Broad Therapeutic Applications
Numerous therapeutic fields stand to gain from Gelteq's gel-based delivery system, particularly neurology, inflammation and pain management, hormonal therapies, and even veterinary health. These areas frequently involve lipid-based or poorly soluble APIs, where enhanced absorption can significantly improve clinical efficacy.
Positioning Gelteq as a Key Development Partner
With its gel-based delivery system, Gelteq positions itself as an indispensable ally for pharmaceutical and nutraceutical companies. By enabling consistent absorption, targeted delivery, and diminished reliance on excipients, Gelteq provides essential support for organizations looking to reformulate existing products or conquer complex formulation challenges in their developmental pipelines.
About Gelteq Ltd.
Headquartered in Melbourne, Gelteq (NASDAQ: GELS) specializes in creating an innovative drug delivery platform that introduces an ingestible gel form. The company is dedicated to the formulation, development, and production of gel products catering to licensed partners across pharmaceutical, consumer health, and animal health sectors. By addressing conventional drug and nutrient delivery challenges, Gelteq aims to enhance bioavailability, improve patient adherence, and provide precise dosing.
Contact Information
For inquiries, please contact Gelteq Investor Relations:
Matt Kreps, Darrow Associates IR
+1-214-597-8200
mkreps@darrowir.com
Frequently Asked Questions
What is Gelteq's gel-based delivery system?
Gelteq's gel-based delivery system is an innovative platform designed to enhance the oral absorption of oil-soluble and poorly soluble drugs.
How does Gelteq's platform improve drug absorption?
The platform has shown to improve absorption significantly, with a notable increase in bioavailability during the initial hours after administration.
What therapeutic areas can benefit from Gelteq's technology?
Therapeutic areas such as neurology, inflammation management, and oncology could greatly benefit from improved drug absorption and efficacy.
What are the safety profiles of Gelteq's gel formulations?
The gel formulations have demonstrated safety and compatibility with oral administration, ensuring effective transit through the digestive system.
How can pharmaceutical companies collaborate with Gelteq?
Gelteq is open to partnerships with pharmaceutical companies seeking to reformulate existing drugs or tackle complex formulation challenges using their gel technology.
